Mrv1572004221604072D 17 16 0 0 0 0 999 V2000 -1.4736 -2.6555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1881 -1.4180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6698 2.7070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4948 1.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1552 1.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3843 -0.1805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3843 0.6445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6698 -0.5930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0447 0.6445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6698 1.0570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0447 -0.1805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7591 -1.4180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4736 -1.8305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.6698 1.8820 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 -0.0447 -1.8305 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.7591 -0.5930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.8520 0.0000 0.0000 Br 0 5 0 0 0 0 0 0 0 0 0 0 7 6 2 0 0 0 0 8 6 1 0 0 0 0 10 7 1 0 0 0 0 10 9 2 0 0 0 0 11 8 2 0 0 0 0 11 9 1 0 0 0 0 13 1 1 0 0 0 0 13 2 1 0 0 0 0 13 12 1 0 0 0 0 14 3 1 0 0 0 0 14 4 1 0 0 0 0 14 5 1 0 0 0 0 14 10 1 0 0 0 0 15 12 2 0 0 0 0 16 11 1 0 0 0 0 16 12 1 0 0 0 0 M CHG 2 14 1 17 -1 M END > DBSALT001191 > drugbank > [Br-].CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C > InChI=1S/C12H19N2O2.BrH/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;/h6-9H,1-5H3;1H/q+1;/p-1 > LULNWZDBKTWDGK-UHFFFAOYSA-M > C12H19BrN2O2 > 303.2 > 302.062991 > 1 > 36 > 25.113290164477135 > 1 > 0 > 0 > 0 > 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium bromide > -2.45 > -2.2459823888050785 > -4.28 > 0 > 1 > 1 > 29.540000000000003 > 75.2818 > 3 > 1 > 1.60e-02 g/l > neostigmine bromide > 1 > DBSALT001191 > Neostigmine bromide > DB01400 > Neostigmine > 114-80-7 > 005SYP50G5 $$$$